Sleep Archives - Purablis-Medicinal Tinctures with CBD, THCA and THC

Sleep Marijuana Studies and

Sleep Cannabis Research


Author(s): David A. Gorelick, Robert S. Goodwin, Eugene Schwilke, Jennifer R. Schroeder, David M. Schwope, Deanna L. Kelly, Pharm, Catherine Ortemann‐Renon, Denis Bonnet, Marilyn A. Huestis.

In this study it has been shown that THC could promote sleep, since its clinical use is associated with drowsiness. View study


Author(s): L. Robinson, A. Plano, A. Goonawardena, B. Platt, G. Riedel.

The endocannabinoid system is involved in the modulation of sleep. In addition, this study leads to affirm that cannabinoid agonists could be used in order to treat sleep disorders. View study


Author(s): D. M. Paton and R. G. Pertwee.

Cannabis extract prolonged sleeping time in mice in a thermally neutral environment (30-32′ C) in which hypothermia does not occur. Cannabis extract inhibits microsomal activity of mouse liver, chiefly by virtue of its cannabidiol content. It is probable that cannabis consumption by man could lead to altered disposal of many other drugs, used in medicine or otherwise. View study


Author(s): Eric Murillo-Rodrıguez Diana Millan-Aldaco and Marcela Palomero-Rivero Raphael Mechoulam Rene Drucker-Colın.

The biological actions of CBD in sleep indicate that it is an inducer of the wake that presumably activates the neurons in LH and DRN, since it increases wakefulness and slows down slow wave sleep and REM sleep. View study


The Emerging Role of the Endocannabinoid System in the Sleep-Wake Cycle Modulation. (2011).

Author(s): Eric Murillo-Rodríguez1,*, Alwin Poot-Ake1, Oscar Arias-Carrión2, Elda Pacheco-Pantoja1,Alfredo de la Fuente-Ortegón1 and Gloria Arankowsky-Sandoval3.

Pharmacological experiments have shown that the administration of endocannabinoids induces cannabimimetic effects, including sleep promotion. View study


Author(s): Bharati Prasad, Miodrag G. Radulovacki and David W. Carley.

Dronabinol has been shown to be safe and well tolerated to treat patients with obstructive sleep apnea and greatly reduces AHI. View study


Intranodose ganglion injections of dronabinol attenuate serotonin-induced apnea in Sprague-Dawley rat. (2014).

Author(s): Michael W. Calik, Miodrag Radulovacki, and David W. Carley.

Dronabinol stabilizes the respiratory pattern and increases the muscles of the upper respiratory tract acting on the nodose ganglia, which highlights its therapeutic potential for the treatment of obstructive sleep apnea. View study


Author(s): Pavel Ernesto Rueda-Orozco∗, Edgar Soria-Gómez, Corinne Jennifer Montes-Rodríguez, Marcel Pérez-Morales, Oscar Prospéro-García.

Endocannabinoids administered to the hippocampus elicit REM and support previous studies in which chemical stimulation of the limbic areas triggered sleep. View study